Novartis confirms 'thousands' of layoffs loom as its global reorganization rolls ahead

After Novartis drafted plans to wed its pharma and oncology businesses earlier this month, reports of potential layoffs poured in. Now, as Novartis taps prolific Wall Street analyst Ronny Gal to spearhead M&A, the company has confirmed that thousands of positions could be under threat.